A biotech round this week pushed total raised past $845M toward a $2B valuation, pre-major-catalyst. When does "well-capitalized" become "overcapitalized"?

Options

• When burn stops matching milestones
• When founders can't name what the next dollar buys
• Never in this environment — capital is the moat now
• I genuinely can't tell anymore, and that worries me a little